A review published in Lancet Oncology (2008) examined treatments for locally advanced prostate cancer, including prostatectomy, external beam radiation therapy (EBRT) combined with gonadorelin agonists, and androgen suppression. The study found that prostatectomy has a 2% to 16% cancer-specific mortality rate over five years, but with significant side effects like
